Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Khiron Life Sciences Corp V.KHRN.H

Alternate Symbol(s):  KHRNF | KHRWF | V.KHRN.WT.H

Khiron Life Sciences Corp. is a Canada-based medical cannabis company with core operations in Latin America. The Company has its wholly owned medical health clinics and telemedicine platforms. The Company has two product lines: Medical Cannabis Products and Health Services. It sells branded medical cannabis products to patients with medical conditions. Under the Medical Cannabis Products line... see more

TSXV:KHRN.H - Post Discussion

Khiron Life Sciences Corp > 40 cents floor resistance broken
View:
Post by Bu11ish0NG0ld on Nov 12, 2020 4:19pm

40 cents floor resistance broken

My best guess 30 cents will be the new floor. GLTA!!
Comment by Benedictus on Nov 14, 2020 12:35am
Unfortunately I agree. Unless the stock retakes.40 and climbs/stays above .42, there is a real risk of further erosion in the share price. The very dilutive financing provides a little more than 2 months of the current cash burn rate. At potentially 190M shares o/s (assuming over-allotment and warrant conversion), .30 would actually value the company at the same market cap where it was when it was ...more  
Comment by ORTsnort on Nov 16, 2020 7:57am
Super uneducated short seller scare tactics here.  Way more than two months of runway.  !!  They will be cash flow neutral early next year!  Prescriptions are growing rapidly too. The stock should be $.60 in the near future
Comment by Benedictus on Nov 17, 2020 12:21am
You can believe I'm an uneducated idiot all you want ORT. It doesn't change the fact that management lost a ton of credibility by doing this pp with so much cash on hand. Worse yet, according to the lataest update from Ted Ohashi, this pp was done merely because the "opportunity presented itself". A potentially 50% dilution done with plenty of cash on hand and the share price ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities